Jpmorgan Chase & CO Viatris Inc Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Viatris Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 7,334,228 shares of VTRS stock, worth $91.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,334,228

Previous 5,085,138 44.23%

Holding current value

$91.1 Million

Previous $54.1 Million 57.52%

% of portfolio

0.01%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Dec 26, 2024	BUY	$10.32 - $12.13 $23.2 Million - $27.3 Million	2,249,090 Added 44.23%	7,334,228 $85.2 Million
Q3 2024 Nov 08, 2024	BUY	$10.32 - $12.13 $23.2 Million - $27.3 Million	2,249,090 Added 44.23%	7,334,228 $85.2 Million
Q2 2024 Dec 26, 2024	SELL	$10.05 - $12.02 $22.6 Million - $27 Million	-2,249,090 Reduced 30.67%	5,085,138 $54.1 Million
Q2 2024 Aug 12, 2024	SELL	$10.05 - $12.02 $35.2 Million - $42.1 Million	-3,505,732 Reduced 40.81%	5,085,138 $54.1 Million
Q1 2024 Dec 26, 2024	BUY	$11.27 - $13.53 $14.2 Million - $17 Million	1,256,642 Added 17.13%	8,590,870 $103 Million
Q1 2024 May 10, 2024	BUY	$11.27 - $13.53 $45.5 Million - $54.6 Million	4,032,854 Added 88.48%	8,590,870 $103 Million
Q4 2023 Dec 26, 2024	SELL	$8.77 - $10.85 $24.3 Million - $30.1 Million	-2,776,212 Reduced 37.85%	4,558,016 $49.4 Million
Q4 2023 Feb 12, 2024	SELL	$8.77 - $10.85 $3.97 Million - $4.91 Million	-452,110 Reduced 9.02%	4,558,016 $49.4 Million
Q3 2023 Nov 14, 2023	SELL	$9.59 - $11.35 $1.78 Million - $2.11 Million	-185,474 Reduced 3.57%	5,010,126 $49.4 Million
Q2 2023 Aug 11, 2023	BUY	$9.02 - $10.29 $20.4 Million - $23.3 Million	2,260,285 Added 77.0%	5,195,600 $51.9 Million
Q1 2023 May 18, 2023	BUY	$9.2 - $12.26 $5.25 Million - $7 Million	570,678 Added 24.13%	2,935,315 $28.2 Million
Q1 2023 May 11, 2023	SELL	$9.2 - $12.26 $30 Million - $39.9 Million	-3,258,164 Reduced 57.95%	2,364,637 $22.7 Million
Q4 2022 Feb 13, 2023	BUY	$8.72 - $11.56 $14.9 Million - $19.7 Million	1,707,554 Added 43.61%	5,622,801 $62.6 Million
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $7.78 Million - $10.2 Million	917,367 Added 30.6%	3,915,247 $33.4 Million
Q2 2022 Aug 11, 2022	SELL	$9.95 - $12.27 $31 Million - $38.2 Million	-3,113,669 Reduced 50.95%	2,997,880 $31.4 Million
Q1 2022 May 11, 2022	SELL	$9.81 - $15.4 $19.9 Million - $31.2 Million	-2,028,906 Reduced 24.92%	6,111,549 $66.5 Million
Q4 2021 Feb 10, 2022	SELL	$12.09 - $14.68 $17 Million - $20.6 Million	-1,402,033 Reduced 14.69%	8,140,455 $110 Million
Q3 2021 Nov 12, 2021	BUY	$13.25 - $15.13 $126 Million - $144 Million	9,542,488 New	9,542,488 $129 Million

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

933M

Call Options Held

2.71M

Put Options Held

2.4M

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.1B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Viatris Inc Transaction History